Agent for therapy
US5128322A · kind A · utility
1Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 25, 1991 |
| Grant date | Jul 7, 1992 |
| Priority date | — |
| Expiry date | Jun 25, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a novel therapeutic agent for use in the prevention or treatment of hemorrhage associated with acute nonlymphocytic leukemia or its therapy, as well as a method of prevention or treatment of hemorrhage associated with acute nonlymphocytic leukemia or its therapy with the therapeutic agent, and a method of prevention or treatment of hemorrhage associated with acute nonlymphocytic leukemia or its therapy with the therapeutic agent in combination with one or more other agents indicated for the treatment of acute nonlymphocytic leukemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.